TheraBrex
Natural health product licensed in Canada
- Other names
- Bio-PEA, Canadabrex
- Licence holder
- Theralogix LLC
- NPN or DIN-HM
- 80111117
- Status
- Active licence
- Licence date
- 30 June 2021
- Revision date
- 27 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(2-Hydroxyéthyl)hexadécanamide Source : Palmitoyléthanolamide | 300 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Huile de coco fractionnée, Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium, des mono- et diglycérides d'acides gras, Lécithine, Huile essentielle de Citrus aurantifolia (Lime), Esters de poly(glycérol) d'acide ricinoléique interestérifié, Huile essentielle de pelure de citron
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 par jour |
| Adultes | Not specified | 2 Capsule | 2 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Studies show that PEA helps to relieve chronic pain. Helps to relieve minor pain. Analgesic to help relieve minor pain. Studies show that PEA may be used as an anti-inflammatory to help relieve pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80111117
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.